Factors Contributing to the High Prevalence of Multidrug-Resistant Tuberculosis Among Previously Treated Patients: A Case–Control Study from China
Authors:
- 1 August 2014
- journal article
- research article
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 20 (4) , 294-300
Abstract
Setting: Multidrug-resistant tuberculosis (MDR-TB) has emerged as a serious global public health problem. In China, the risk factors for MDR-TB have not been systematically evaluated. Objective: To identify risk factors associated with MDR-TB among previously treated patients in China. Design: A case–control study was carried out. Cases were selected from previously treated MDR-TB patients who were resistant to both isoniazid and rifampin, and controls were selected from previously treated TB patients who were sensitive to isoniazid and rifampin (non-MDR-TB). Information was collected from the registration database and a structured questionnaire. Results: A total of 61 cases and 50 controls were recruited. A multivariate analysis showed that the family annual per-capita income ≤7,000 Yuan (odds ratio [OR]=3.238; 95% confidence interval [CI]: 1.270–8.252), no history of fixed dose combinations (FDCs) in anti-TB treatment (OR=4.027; 95% CI: 1.457–11.129), and adverse reactions in the course of TB treatment (OR=3.568; 95% CI: 1.402–9.085) were independent predictors of MDR-TB. Moreover, among the TB patients who had adverse reactions, quitting the treatment was shown as a risk factor for MDR-TB ( p =0.009). Conclusion: In the control of MDR-TB among previously treated patients, lower socioeconomic groups, the expanding use of FDCs, and improving adherence to treatment by implementing Directly Observed Therapy Short Course-Plus (DOTS-Plus), strictly should become a priority that requires strong commitment and collaboration among health organizations.Keywords
This publication has 16 references indexed in Scilit:
- Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from ChinaThorax, 2012
- Multidrug-Resistant Tuberculosis, People’s Republic of China, 2007–2009Emerging Infectious Diseases, 2011
- Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April – September 2009Eurosurveillance, 2010
- First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran—eight years of surveillanceInternational Journal of Infectious Diseases, 2009
- Risk factors for multidrug resistant tuberculosis in Europe: a systematic reviewThorax, 2006
- Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, RussiaThorax, 2005
- Risk factors for drug resistant tuberculosis in Leicestershire – poor adherence to treatment remains an important cause of resistanceEpidemiology and Infection, 2003
- A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UKThorax, 2002
- Global Trends in Resistance to Antituberculosis DrugsNew England Journal of Medicine, 2001
- Tuberculosis in Bombay: New Insights from Poor Urban PatientsHealth Policy and Planning, 1997